Bio-Rad Laboratories, Inc.Class A vs. 10x Genomics, Inc. Class A Common Stock
BIO
Bio-Rad Laboratories, Inc.Class A
$381.76 +0.46%
VS TXG10x Genomics, Inc. Class A Common Stock
$63.80 -2.03%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BIO | TXG | |
|---|---|---|
| Market Cap | $10.21 billion | $8.31 billion |
| Revenue (TTM) | $2.59 billion | $616.91 million |
| Net Income (TTM) | $222.40 million | $-75,125,000 |
BIO leads on 3 of 3 size & scale factors.
Valuation
| BIO | TXG | |
|---|---|---|
| P/E Ratio | 46.50 | — |
| Price / Book | 1.42 | 10.07 |
| Price / Sales | 3.94 | 13.47 |
BIO leads on 2 of 2 valuation factors.
Profitability
| BIO | TXG | |
|---|---|---|
| Net Margin | 8.59% | -12.18% |
| Return on Equity | 3.10% | -9.10% |
BIO leads on 2 of 2 profitability factors.
Risk & Sentiment
| BIO | TXG | |
|---|---|---|
| Short Interest | 2.44% | 0.42% |
TXG leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, TXG overview, TXG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.